Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (11 ops.)
Latest filing published 26 Aug 2026 for Rapport Therapeutics, Inc., €563k.
Filing timeline
BuySaleKrishnaswamy Yeleswaram
Insider track record
Disclosed buys
0
Disclosed sells
11
Signal history
Krishnaswamy Yeleswaram: trading record in brief
Krishnaswamy Yeleswaram is a declared insider of Rapport Therapeutics, Inc., with filings sourced from SEC (Form 4). The record holds 12 filings, for trades running from 31 December 2025 to 25 August 2026.
Sales make up the whole of the open-market record (11 sales, €3.8M). Besides market trades, the filings include 1 share grant. In 2026 alone, the filings show no purchases and 11 sales.
The record was last updated on 26 August 2026 with an open-market sale (€563k) in Rapport Therapeutics, Inc. Typically, a trade is published a median of 1 day after it takes place. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Krishnaswamy Yeleswaram
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations11 total
13,160 shares@ US$49.99830.039% mcap15.1% of flowCommon StockSEC:0001193125-26-368244:0
20,799 shares@ US$50.31110.063% mcap24.0% of flowCommon StockSEC:0001193125-26-368244:1
16,201 shares@ US$51.05760.050% mcap19.0% of flowCommon StockSEC:0001193125-26-368244:2
404 shares@ US$49.900.0012% mcap0.5% of flowCommon StockSEC:0001193125-26-359189:0
20,225 shares@ US$39.99230.041% mcap18.4% of flowCommon StockSEC:0001193125-26-167091:0
500 shares@ US$34.980.0009% mcap0.4% of flowCommon StockSEC:0001193125-26-154908:0
9,165 shares@ US$34.9740.016% mcap7.3% of flowCommon StockSEC:0001193125-26-154908:1
10,200 shares@ US$35.07810.018% mcap8.1% of flowCommon StockSEC:0001193125-26-154908:2
360 shares@ US$34.900.3% of flowCommon StockSEC:0001193125-26-149725:0
10,115 shares@ US$29.99067.0% of flowCommon StockSEC:0001193125-26-126410:0
9,000 sharesCommon StockSEC:0001193125-26-002469:0
11 of 11 declarations
